GGrantIndex
← Leaderboards

Michael T McMahon

Hugo W. Moser Res Inst Kennedy Krieger

$10,109,578
Attributed
$11,021,418
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY200625
$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,021,418 · 8

By mechanism

R01$6,698,644 · 4
S10$2,000,000 · 1
P41$1,625,046 · 1
K01$618,684 · 1
F32$79,044 · 1

Top collaborators

Most similar at Hugo W. Moser Res Inst Kennedy Krieger

Same institution · by research overlap

Others in their field

Top investigators on “Image

Research focus

ImageMonitorMagnetic Resonance ImagingIn VitroDetectionContrast MediaBaseDesignSignal TransductionGadoliniumToxic EffectPhysiologic PulseIn VivoProteinsProtonsCellsTissuesFrequenciesMalignant NeoplasmsLysinePropertyPre-ClinicalRelaxationResolution

Grant awards (28)

Multimodal dendrimer theranostics targeting aggressive subtypes of prostate cancer$675,688
R01 · FY2025 · CA
Multimodal dendrimer theranostics targeting aggressive subtypes of prostate cancer$692,072
R01 · FY2024 · CA
Developing MRI contrast agents to detect progression in renal disease as a consequence of acidema$395,652
R01 · FY2023 · DK · contact PI
Developing MRI contrast agents to detect progression in renal disease as a consequence of acidema$395,652
R01 · FY2022 · DK · contact PI
Developing MRI contrast agents to detect progression in renal disease as a consequence of acidema$395,652
R01 · FY2021 · DK · contact PI
CEST MRI Agents for Receptor Imaging$256,587
P41 · FY2021 · EB · contact PI
Developing MRI contrast agents to detect progression in renal disease as a consequence of acidema$426,396
R01 · FY2020 · DK · contact PI
CEST MRI Agents for Receptor Imaging$260,599
P41 · FY2020 · EB · contact PI
CEST MRI Agents for Receptor Imaging$310,425
P41 · FY2019 · EB · contact PI
CEST MRI Agents for Receptor Imaging$260,599
P41 · FY2019 · EB · contact PI
CEST MRI Agents for Receptor Imaging$260,599
P41 · FY2018 · EB · contact PI
CEST MRI Agents for Receptor Imaging$276,237
P41 · FY2017 · EB · contact PI
Multi-Color Exchange Transfer Imaging of Drug Delivery Nanocarriers$565,192
R01 · FY2014 · EB · contact PI
Multi-Color Exchange Transfer Imaging of Drug Delivery Nanocarriers$578,118
R01 · FY2013 · EB · contact PI
DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing$328,348
R01 · FY2013 · EB · contact PI
Multi-Color Exchange Transfer Imaging of Drug Delivery Nanocarriers$609,588
R01 · FY2012 · EB · contact PI
DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing$348,195
R01 · FY2012 · EB · contact PI
Multi-Color Exchange Transfer Imaging of Drug Delivery Nanocarriers$618,877
R01 · FY2011 · EB · contact PI
DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing$338,036
R01 · FY2011 · EB · contact PI
DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing$331,178
R01 · FY2010 · EB · contact PI
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking$132,039
K01 · FY2010 · EB · contact PI
16.4T Vertical Wide Bore Animal MR Imager$2,000,000
S10 · FY2009 · RR · contact PI
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking$128,193
K01 · FY2009 · EB · contact PI
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking$124,459
K01 · FY2008 · EB · contact PI
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking$118,087
K01 · FY2007 · EB · contact PI
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking$115,906
K01 · FY2006 · EB · contact PI
A SOLID STATE NMR INVESTIGATION OF BACTERIORHODOPSIN$44,212
F32 · FY2002 · GM
A SOLID STATE NMR INVESTIGATION OF BACTERIORHODOPSIN$34,832
F32 · FY2001 · GM